25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Appili Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Appili Therapeutics Inc together

I guess you are interested in Appili Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Appili Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Appili Therapeutics Inc

I send you an email if I find something interesting about Appili Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Appili Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Appili Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.07
Expected worth in 1 year
$-0.09
How sure are you?
18.2%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-89.0%

For what price can you sell your share?

Current Price per Share
$0.02
Expected price per share
$0.02 - $0.0349
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Appili Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.02
Intrinsic Value Per Share
$1.49 - $1.82
Total Value Per Share
$1.42 - $1.74

2.2. Growth of Appili Therapeutics Inc (5 min.)




Is Appili Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$8.8m-$4.3m-$3.2m-42.6%

How much money is Appili Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$682.6k-$1.5m$831.4k121.8%
Net Profit Margin-2,438.8%-199.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Appili Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#886 / 954

Most Revenue
#652 / 954

Most Profit
#215 / 954

Most Efficient
#792 / 954
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Appili Therapeutics Inc?

Welcome investor! Appili Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Appili Therapeutics Inc.

First you should know what it really means to hold a share of Appili Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Appili Therapeutics Inc is $0.024. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Appili Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Appili Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.07. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Appili Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-39.0%-0.01-23.5%-0.01-45.2%-0.02-69.5%-0.02-66.7%
Usd Book Value Change Per Share-0.01-35.9%-0.01-22.2%-0.01-35.1%0.00-18.8%0.00-13.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-35.9%-0.01-22.2%-0.01-35.1%0.00-18.8%0.00-13.8%
Usd Price Per Share0.03-0.03-0.03-0.27-0.25-
Price to Earnings Ratio-0.80--2.73--0.72--3.45--3.14-
Price-to-Total Gains Ratio-3.48--12.05--2.48--16.11--16.11-
Price to Book Ratio-0.41--0.48--1.08--1.99--1.81-
Price-to-Total Gains Ratio-3.48--12.05--2.48--16.11--16.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.024
Number of shares41666
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (41666 shares)-222.38-187.56
Gains per Year (41666 shares)-889.51-750.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-890-9000-750-760
20-1779-17900-1500-1510
30-2669-26800-2251-2260
40-3558-35700-3001-3010
50-4448-44600-3751-3760
60-5337-53500-4501-4510
70-6227-62400-5252-5260
80-7116-71300-6002-6010
90-8006-80200-6752-6760
100-8895-89100-7502-7510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.022.00.00.0%0.022.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.010.01.08.3%3.016.01.015.0%4.017.01.018.2%4.017.01.018.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.022.00.0%0.00.022.00.0%
Total Gains per Share0.04.00.00.0%1.010.01.08.3%3.016.01.015.0%4.017.01.018.2%4.017.01.018.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Appili Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.009-0.005-38%-0.008-2%-0.005-48%-0.003-61%
Book Value Per Share---0.073-0.063-14%-0.036-50%0.004-1781%0.006-1337%
Current Ratio--0.1600.306-48%1.254-87%3.213-95%3.321-95%
Debt To Asset Ratio--6.5476.706-2%3.313+98%2.410+172%2.227+194%
Debt To Equity Ratio----0%-0%0.324-100%0.355-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.009-0.006-40%-0.011+16%-0.017+78%-0.016+71%
Free Cash Flow Per Share---0.001-0.001+15%-0.011+1266%-0.013+1539%-0.012+1464%
Free Cash Flow To Equity Per Share--0.0010.000+127%-0.010+959%-0.003+307%-0.002+298%
Gross Profit Margin--1.0011.100-9%1.019-2%1.028-3%1.025-2%
Intrinsic Value_10Y_max--1.816--------
Intrinsic Value_10Y_min--1.491--------
Intrinsic Value_1Y_max---0.011--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max--0.114--------
Intrinsic Value_3Y_min--0.105--------
Intrinsic Value_5Y_max--0.416--------
Intrinsic Value_5Y_min--0.373--------
Market Cap2910384.000-25%3637983.6003607667.070+1%3698616.660-2%32843686.362-89%29857896.693-88%
Net Profit Margin----24.3880%-1.9900%-6.3140%-5.7400%
Operating Margin----52.6550%-0%-11.3180%-10.2890%
Operating Ratio---53.715-100%1.908-100%11.965-100%10.877-100%
Pb Ratio-0.328+20%-0.411-0.480+17%-1.076+162%-1.995+386%-1.813+342%
Pe Ratio-0.642+20%-0.802-2.725+240%-0.719-10%-3.451+330%-3.138+291%
Price Per Share0.024-25%0.0300.030+1%0.031-2%0.271-89%0.246-88%
Price To Free Cash Flow Ratio-7.702+20%-9.627-3.493-64%-0.884-91%-4.767-50%-4.333-55%
Price To Total Gains Ratio-2.784+20%-3.480-12.053+246%-2.483-29%-16.107+363%-16.107+363%
Quick Ratio--0.1520.167-9%0.852-82%3.892-96%3.915-96%
Return On Assets---0.710-0.507-29%-0.749+5%-0.455-36%-0.438-38%
Return On Equity----0%-0%-0.2250%-0.2470%
Total Gains Per Share---0.009-0.005-38%-0.008-2%-0.005-48%-0.003-61%
Usd Book Value---8859811.664-7660689.897-14%-4394061.970-50%527121.809-1781%716436.709-1337%
Usd Book Value Change Per Share---0.009-0.005-38%-0.008-2%-0.005-48%-0.003-61%
Usd Book Value Per Share---0.073-0.063-14%-0.036-50%0.004-1781%0.006-1337%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.009-0.006-40%-0.011+16%-0.017+78%-0.016+71%
Usd Free Cash Flow---94473.248-108632.611+15%-1290631.348+1266%-1548148.468+1539%-1477491.231+1464%
Usd Free Cash Flow Per Share---0.001-0.001+15%-0.011+1266%-0.013+1539%-0.012+1464%
Usd Free Cash Flow To Equity Per Share--0.0010.000+127%-0.010+959%-0.003+307%-0.002+298%
Usd Market Cap2910384.000-25%3637983.6003607667.070+1%3698616.660-2%32843686.362-89%29857896.693-88%
Usd Price Per Share0.024-25%0.0300.030+1%0.031-2%0.271-89%0.246-88%
Usd Profit---1133686.838-682621.877-40%-1514078.014+34%-2005306.068+77%-1923975.574+70%
Usd Revenue---147961.057-100%59759.202-100%72680.918-100%66073.562-100%
Usd Total Gains Per Share---0.009-0.005-38%-0.008-2%-0.005-48%-0.003-61%
 EOD+2 -6MRQTTM+12 -18YOY+13 -175Y+13 -1810Y+13 -18

3.3 Fundamental Score

Let's check the fundamental score of Appili Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.642
Price to Book Ratio (EOD)Between0-1-0.328
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.152
Current Ratio (MRQ)Greater than10.160
Debt to Asset Ratio (MRQ)Less than16.547
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.710
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Appili Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.396
Ma 20Greater thanMa 500.025
Ma 50Greater thanMa 1000.024
Ma 100Greater thanMa 2000.025
OpenGreater thanClose0.020
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Appili Therapeutics Inc

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

Fundamental data was last updated by Penke on 2024-11-15 11:04:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Appili Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Appili Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,438.8%+2,438.8%
TTM-2,438.8%YOY-199.0%-2,239.7%
TTM-2,438.8%5Y-631.4%-1,807.4%
5Y-631.4%10Y-574.0%-57.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--120.2%+120.2%
TTM-2,438.8%-210.7%-2,228.1%
YOY-199.0%-219.8%+20.8%
5Y-631.4%-348.0%-283.4%
10Y-574.0%-473.2%-100.8%
4.3.1.2. Return on Assets

Shows how efficient Appili Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • -71.0% Return on Assets means that Appili Therapeutics Inc generated $-0.71 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Appili Therapeutics Inc:

  • The MRQ is -71.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -50.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-71.0%TTM-50.7%-20.3%
TTM-50.7%YOY-74.9%+24.2%
TTM-50.7%5Y-45.5%-5.2%
5Y-45.5%10Y-43.8%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-71.0%-11.0%-60.0%
TTM-50.7%-11.8%-38.9%
YOY-74.9%-11.3%-63.6%
5Y-45.5%-12.6%-32.9%
10Y-43.8%-14.3%-29.5%
4.3.1.3. Return on Equity

Shows how efficient Appili Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Appili Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Appili Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-22.5%+22.5%
5Y-22.5%10Y-24.7%+2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.8%+15.8%
YOY--13.9%+13.9%
5Y-22.5%-18.5%-4.0%
10Y-24.7%-19.2%-5.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Appili Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Appili Therapeutics Inc is operating .

  • Measures how much profit Appili Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Appili Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-5,265.5%+5,265.5%
TTM-5,265.5%YOY--5,265.5%
TTM-5,265.5%5Y-1,131.8%-4,133.7%
5Y-1,131.8%10Y-1,028.9%-102.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--267.8%+267.8%
TTM-5,265.5%-313.4%-4,952.1%
YOY--224.0%+224.0%
5Y-1,131.8%-385.5%-746.3%
10Y-1,028.9%-498.7%-530.2%
4.3.2.2. Operating Ratio

Measures how efficient Appili Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM53.715-53.715
TTM53.715YOY1.908+51.807
TTM53.7155Y11.965+41.750
5Y11.96510Y10.877+1.088
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.631-2.631
TTM53.7153.412+50.303
YOY1.9083.299-1.391
5Y11.9654.788+7.177
10Y10.8776.538+4.339
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Appili Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Appili Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.16 means the company has $0.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.160. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.306. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.306-0.146
TTM0.306YOY1.254-0.947
TTM0.3065Y3.213-2.907
5Y3.21310Y3.321-0.108
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1603.690-3.530
TTM0.3063.875-3.569
YOY1.2544.684-3.430
5Y3.2135.946-2.733
10Y3.3216.274-2.953
4.4.3.2. Quick Ratio

Measures if Appili Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.15 means the company can pay off $0.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.152. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.167. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.167-0.015
TTM0.167YOY0.852-0.685
TTM0.1675Y3.892-3.725
5Y3.89210Y3.915-0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1523.122-2.970
TTM0.1673.451-3.284
YOY0.8524.498-3.646
5Y3.8925.922-2.030
10Y3.9156.414-2.499
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Appili Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Appili Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Appili Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 6.55 means that Appili Therapeutics Inc assets are financed with 654.7% credit (debt) and the remaining percentage (100% - 654.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 6.547. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 6.706. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ6.547TTM6.706-0.159
TTM6.706YOY3.313+3.393
TTM6.7065Y2.410+4.296
5Y2.41010Y2.227+0.183
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5470.353+6.194
TTM6.7060.350+6.356
YOY3.3130.311+3.002
5Y2.4100.367+2.043
10Y2.2270.382+1.845
4.5.4.2. Debt to Equity Ratio

Measures if Appili Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Appili Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.324-0.324
5Y0.32410Y0.355-0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.435-0.435
YOY-0.378-0.378
5Y0.3240.451-0.127
10Y0.3550.493-0.138
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Appili Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Appili Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.80 means the investor is paying $-0.80 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Appili Therapeutics Inc:

  • The EOD is -0.642. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.802. Based on the earnings, the company is expensive. -2
  • The TTM is -2.725. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.642MRQ-0.802+0.160
MRQ-0.802TTM-2.725+1.923
TTM-2.725YOY-0.719-2.006
TTM-2.7255Y-3.451+0.726
5Y-3.45110Y-3.138-0.314
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.642-2.126+1.484
MRQ-0.802-2.454+1.652
TTM-2.725-3.147+0.422
YOY-0.719-3.335+2.616
5Y-3.451-6.070+2.619
10Y-3.138-6.597+3.459
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Appili Therapeutics Inc:

  • The EOD is -7.702. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.627. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.493. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.702MRQ-9.627+1.925
MRQ-9.627TTM-3.493-6.134
TTM-3.493YOY-0.884-2.610
TTM-3.4935Y-4.767+1.273
5Y-4.76710Y-4.333-0.433
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.702-2.981-4.721
MRQ-9.627-3.363-6.264
TTM-3.493-3.667+0.174
YOY-0.884-4.535+3.651
5Y-4.767-8.343+3.576
10Y-4.333-9.276+4.943
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Appili Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.41 means the investor is paying $-0.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Appili Therapeutics Inc:

  • The EOD is -0.328. Based on the equity, the company is expensive. -2
  • The MRQ is -0.411. Based on the equity, the company is expensive. -2
  • The TTM is -0.480. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.328MRQ-0.411+0.082
MRQ-0.411TTM-0.480+0.069
TTM-0.480YOY-1.076+0.596
TTM-0.4805Y-1.995+1.515
5Y-1.99510Y-1.813-0.181
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.3281.863-2.191
MRQ-0.4112.028-2.439
TTM-0.4802.339-2.819
YOY-1.0762.391-3.467
5Y-1.9953.666-5.661
10Y-1.8134.360-6.173
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets2,233
Total Liabilities14,619
Total Stockholder Equity-12,386
 As reported
Total Liabilities 14,619
Total Stockholder Equity+ -12,386
Total Assets = 2,233

Assets

Total Assets2,233
Total Current Assets2,206
Long-term Assets27
Total Current Assets
Cash And Cash Equivalents 301
Net Receivables 1,788
Other Current Assets 117
Total Current Assets  (as reported)2,206
Total Current Assets  (calculated)2,206
+/-0
Long-term Assets
Property Plant Equipment 27
Long-term Assets  (as reported)27
Long-term Assets  (calculated)27
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,769
Long-term Liabilities850
Total Stockholder Equity-12,386
Total Current Liabilities
Short-term Debt 9,202
Short Long Term Debt 9,202
Accounts payable 4,511
Other Current Liabilities 13
Total Current Liabilities  (as reported)13,769
Total Current Liabilities  (calculated)22,928
+/- 9,159
Long-term Liabilities
Long term Debt 850
Long-term Liabilities  (as reported)850
Long-term Liabilities  (calculated)850
+/-0
Total Stockholder Equity
Common Stock42,323
Retained Earnings -70,678
Other Stockholders Equity 15,969
Total Stockholder Equity (as reported)-12,386
Total Stockholder Equity (calculated)-12,386
+/-0
Other
Capital Stock42,323
Cash and Short Term Investments 301
Common Stock Shares Outstanding 121,266
Liabilities and Stockholders Equity 2,233
Net Debt 9,751
Net Invested Capital -2,334
Net Working Capital -11,563
Short Long Term Debt Total 10,052



6.2. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
0
0
0
6,835
5,157
3,788
3,059
11,174
26,220
23,722
21,534
18,317
11,904
11,893
11,363
7,136
3,907
3,907
2,588
3,132
2,171
1,958
1,968
1,490
2,233
2,2331,4901,9681,9582,1713,1322,5883,9073,9077,13611,36311,89311,90418,31721,53423,72226,22011,1743,0593,7885,1576,835000
   > Total Current Assets 
0
0
0
6,755
5,081
3,716
2,991
11,111
26,160
23,662
21,477
18,262
11,852
11,843
11,316
7,120
3,892
3,892
2,575
3,118
2,130
1,921
1,934
1,460
2,206
2,2061,4601,9341,9212,1303,1182,5753,8923,8927,12011,31611,84311,85218,26221,47723,66226,16011,1112,9913,7165,0816,755000
       Cash And Cash Equivalents 
0
0
0
5,421
4,175
3,041
2,408
10,510
5,526
12,857
15,236
11,063
9,302
9,985
9,372
5,554
2,425
2,425
1,427
2,466
521
396
603
94
301
301946033965212,4661,4272,4252,4255,5549,3729,9859,30211,06315,23612,8575,52610,5102,4083,0414,1755,421000
       Short-term Investments 
0
0
0
30
31
31
30
31
20,034
10,055
5,052
5,062
30
20
0
0
0
0
0
0
0
0
0
0
0
0000000000020305,0625,05210,05520,0343130313130000
       Net Receivables 
0
0
0
917
492
369
351
313
405
417
722
1,686
2,342
1,507
1,706
1,109
1,301
1,106
866
0
1,323
0
1,102
1,173
1,788
1,7881,1731,10201,32308661,1061,3011,1091,7061,5072,3421,686722417405313351369492917000
       Other Current Assets 
0
0
0
282
279
171
162
218
0
0
0
0
30
331
231
286
224
360
282
0
0
0
230
192
117
117192230000282360224286231331300000218162171279282000
   > Long-term Assets 
0
0
0
80
76
72
68
63
61
60
57
55
52
50
47
16
15
15
13
15
41
37
34
30
27
27303437411513151516475052555760616368727680000
       Property Plant Equipment 
0
0
0
80
76
72
68
63
61
60
57
55
52
50
47
16
15
15
13
15
41
37
34
30
27
27303437411513151516475052555760616368727680000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000
> Total Liabilities 
0
0
0
2,415
2,280
1,941
2,328
2,328
3,282
2,682
4,165
5,564
6,042
16,058
11,797
8,721
6,959
6,959
7,944
10,529
10,938
11,655
11,800
12,415
14,619
14,61912,41511,80011,65510,93810,5297,9446,9596,9598,72111,79716,0586,0425,5644,1652,6823,2822,3282,3281,9412,2802,415000
   > Total Current Liabilities 
0
0
0
1,350
1,338
997
1,396
1,378
2,332
1,723
3,210
4,617
5,115
15,130
10,872
3,586
1,646
1,646
2,606
2,977
3,467
4,008
4,208
11,540
13,769
13,76911,5404,2084,0083,4672,9772,6061,6461,6463,58610,87215,1305,1154,6173,2101,7232,3321,3781,3969971,3381,350000
       Short-term Debt 
0
0
0
53
58
64
79
55
55
55
83
85
88
2,874
2,078
98
101
101
103
0
0
0
420
7,310
9,202
9,2027,310420000103101101982,0782,87488858355555579645853000
       Short Long Term Debt 
0
0
0
53
58
64
79
55
55
55
83
85
88
0
2,078
96
98
101
103
113
217
355
420
7,310
9,202
9,2027,31042035521711310310198962,078088858355555579645853000
       Accounts payable 
0
0
0
1,288
1,280
889
1,317
1,263
2,278
1,668
3,127
4,531
5,027
0
8,795
3,370
3,619
1,427
2,468
2,823
2,985
3,619
3,749
4,060
4,511
4,5114,0603,7493,6192,9852,8232,4681,4273,6193,3708,79505,0274,5313,1271,6682,2781,2631,3178891,2801,288000
       Other Current Liabilities 
0
0
0
9
0
934
0
1,323
0
0
0
0
0
10,991
118
118
-2,108
118
34
0
53
0
39
123
13
1312339053034118-2,10811811810,991000001,323093409000
   > Long-term Liabilities 
0
0
0
1,066
942
944
933
951
950
959
955
947
927
928
924
5,135
5,313
5,313
5,338
7,552
7,471
7,647
7,592
875
850
8508757,5927,6477,4717,5525,3385,3135,3135,1359249289279479559599509519339449421,066000
> Total Stockholder Equity
0
0
0
4,420
2,877
1,847
731
8,845
22,939
21,041
17,369
12,753
5,862
-4,165
-434
-1,585
-3,052
-3,052
-5,356
-7,397
-8,767
-9,697
-9,831
-10,925
-12,386
-12,386-10,925-9,831-9,697-8,767-7,397-5,356-3,052-3,052-1,585-434-4,1655,86212,75317,36921,04122,9398,8457311,8472,8774,420000
   Common Stock
0
0
0
11,082
14,161
14,161
14,161
20,992
33,804
33,908
34,707
34,962
35,030
35,030
39,653
42,323
42,323
42,323
42,323
0
42,323
0
42,323
42,323
42,323
42,32342,32342,323042,323042,32342,32342,32342,32339,65335,03035,03034,96234,70733,90833,80420,99214,16114,16114,16111,082000
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
6,609
9,179
9,179
3,223
8,815
8,933
0
0
0
2,975
2,975
2,835
2,8352,9752,9750008,9338,8153,2239,1799,1796,6090000000000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
4,547
1,724
1,844
1,908
4,480
8,359
8,832
8,628
8,742
9,152
3,693
12,648
5,307
15,817
5,841
6,039
0
9,179
0
15,835
15,845
15,969
15,96915,84515,83509,17906,0395,84115,8175,30712,6483,6939,1528,7428,6288,8328,3594,4801,9081,8441,7244,547000



6.3. Balance Sheets

Currency in CAD. All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue827
Cost of Revenue-14
Gross Profit814814
 
Operating Income (+$)
Gross Profit814
Operating Expense-827
Operating Income-8,023-14
 
Operating Expense (+$)
Research Development5,830
Selling General Administrative3,047
Selling And Marketing Expenses144
Operating Expense8279,021
 
Net Interest Income (+$)
Interest Income17
Interest Expense-1,631
Other Finance Cost-0
Net Interest Income-1,614
 
Pretax Income (+$)
Operating Income-8,023
Net Interest Income-1,614
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,711-12,362
EBIT - interestExpense = -3,711
-3,711
-2,150
Interest Expense1,631
Earnings Before Interest and Taxes (EBIT)-2,080-2,080
Earnings Before Interest and Taxes (EBITDA)-2,067
 
After tax Income (+$)
Income Before Tax-3,711
Tax Provision-70
Net Income From Continuing Ops-3,781-3,781
Net Income-3,781
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,878
Total Other Income/Expenses Net4,3391,614
 

Technical Analysis of Appili Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Appili Therapeutics Inc. The general trend of Appili Therapeutics Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Appili Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Appili Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.03 < 0.03 < 0.0349.

The bearish price targets are: 0.02 > 0.02 > 0.02.

Tweet this
Appili Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Appili Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Appili Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Appili Therapeutics Inc. The current macd is -0.0008104.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Appili Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Appili Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Appili Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Appili Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAppili Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Appili Therapeutics Inc. The current adx is 14.07.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Appili Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Appili Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Appili Therapeutics Inc. The current sar is 0.02939505.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Appili Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Appili Therapeutics Inc. The current rsi is 49.40. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Appili Therapeutics Inc Daily Relative Strength Index (RSI) ChartAppili Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Appili Therapeutics Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Appili Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Appili Therapeutics Inc Daily Stochastic Oscillator ChartAppili Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Appili Therapeutics Inc. The current cci is -78.95517958.

Appili Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAppili Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Appili Therapeutics Inc. The current cmo is 1.05542763.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Appili Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAppili Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Appili Therapeutics Inc. The current willr is -60.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Appili Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Appili Therapeutics Inc Daily Williams %R ChartAppili Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Appili Therapeutics Inc.

Appili Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Appili Therapeutics Inc. The current atr is 0.00357302.

Appili Therapeutics Inc Daily Average True Range (ATR) ChartAppili Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Appili Therapeutics Inc. The current obv is 8,251,489.

Appili Therapeutics Inc Daily On-Balance Volume (OBV) ChartAppili Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Appili Therapeutics Inc. The current mfi is 4.92626074.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Appili Therapeutics Inc Daily Money Flow Index (MFI) ChartAppili Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Appili Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Appili Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Appili Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.396
Ma 20Greater thanMa 500.025
Ma 50Greater thanMa 1000.024
Ma 100Greater thanMa 2000.025
OpenGreater thanClose0.020
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Appili Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Appili Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Appili Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Appili Therapeutics Inc

I send you an email if I find something interesting about Appili Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Appili Therapeutics Inc.

Receive notifications about Appili Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.